Stay updated with breaking news from Alan Brookhart. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Data from Phase 3 REGENERATE study supporting positive benefit-risk profile of obeticholic acid in liver fibrosis due to NASH to be featured in late-breaker podium presentation Analysis... | October 31, 2022
Target RWE Acquires NoviSci, Gains Amgen Investment Target RWE, a clinical data company based in Durham, didn’t have to go far to find a strategic partner to boost its analytical prowess. The company has acquired NoviSci, a software analysis and services company located in downtown Durham, seven miles away, while also scoring an investment in the newly combined company from California biotech pioneer Amgen. “With the addition of NoviSci’s novel analytics platform and experienced team, Target provides a highly adaptive environment to accelerate insights and reproducible research output f...